SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

SVB Leerink Maintains Market Perform on Nektar Therapeutics, Raises Price Target to $18

SVB Leerink maintains Nektar Therapeutics (NASDAQ:NKTR) with a Market Perform and raises the price target from $17 to $18.

Benzinga · 05/08/2020 15:19

SVB Leerink maintains Nektar Therapeutics (NASDAQ:NKTR) with a Market Perform and raises the price target from $17 to $18.